Treatment of In-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR I)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

November 30, 2006

Study Completion Date

March 31, 2012

Conditions
Coronary Restenosis
Interventions
DEVICE

PTCA

COMBINATION_PRODUCT

paclitaxel coated balloon catheter (device with drug)

Trial Locations (5)

10117

Kardiologie, Campus Mitte, Charite, Berlin

13353

Kardiologie, Campus Virchow-Klinikum, Charite, Berlin

66421

Klinik fuer Innere Medizin III, Universitaetsklinikum des Saarlandes, Homburg / Saar

68167

I. Medizinische Klinik, Universitaetsklinikum, Mannheim

79106

Medizinische Universitätsklinik III, Abt. Kardiologie und Angiologie, Freiburg im Breisgau

All Listed Sponsors
lead

University Hospital, Saarland

OTHER

NCT00106587 - Treatment of In-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR I) | Biotech Hunter | Biotech Hunter